Clinical Trial Update: Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating blue-light photodynamic therapy in combination with sonidegib for multiple basal cell carcinomas is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Blue-Light Photodynamic Therapy
• Sonidegib (Sonidegib)

Snippet

Sponsor: Nathalie Zeitouni | Conditions: Basal Cell Carcinoma (BCC) | Phase 1 | Status: RECRUITING